Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Aug;17(8):RA191-197.
doi: 10.12659/msm.881896.

Treatment strategies in severe symptomatic carotid and coronary artery disease

Affiliations
Review

Treatment strategies in severe symptomatic carotid and coronary artery disease

Karolina Dzierwa et al. Med Sci Monit. 2011 Aug.

Abstract

Coexistent carotid artery stenosis (CS) and multivessel coronary artery disease (CAD) is not infrequent. One in 5 patients with multivessel CAD has a severe CS, and CAD incidence reaches 80% in those referred for carotid revascularization. We reviewed treatment strategies for concomitant severe CS and CAD. We performed a literature search (MEDLINE) with terms including carotid artery stenting (CAS), coronary artery bypass grafting (CABG), carotid endarterectomy (CEA), stroke, and myocardial infarction (MI). The main therapeutic option for CS-CAD has been (simultaneous or staged) CEA-CABG. This, however, is associated with a high risk of MI (in those with CEA prior to CABG) or stroke (CABG prior to CEA), and the cumulative major adverse event rate (MAE - death, stroke or MI) reaches 10-12%. With increasing adoption of CAS, a sequential strategy of CAS followed by CABG has emerged. Registries (usually single-centre) indicate an MAE rate of ≈7% for CAS followed by CABG (frequently after >30 days, due to double antiplatelet therapy). Recently, 1-stage CAS-CABG has been introduced. This involves different antiplatelet regimens and, in some centers, preferred off-pump CABG, with a cumulative MAE of 1.4-4.5%. No randomized trial comparing different treatment strategies in CS-CAD has been conducted, and thus far reported series are prone to selection/reporting bias. In addition to the established surgical treatment (CEA-CABG, sequential/simultaneous), hybrid revascularization (CAS-CABG) is emerging as a viable therapeutic option. Larger, preferably multi-centre, studies are required before this can become widely applied.

PubMed Disclaimer

Figures

Figure 1
Figure 1
An example of the patient with critical RICA stenosis before and after successful CAS procedure in a patient after left hemisphere stroke (occluded LICA) accepted for staged CAS – CABG strategy.
Figure 2
Figure 2
Coronary angiogram of the same patient (CCS class II angina), a critical stenosis of the left main coronary artery (LMCA) and occlusion of the right coronary artery (RCA).
Figure 3
Figure 3
An example of a coronary unstable patient with multivessel coronary artery disease and recurrent TIAs. An electrocardiogram performed during CAS. CAS was immedaitelly followed by CABG.
Figure 4
Figure 4
Coronary angiogram of the same patient: a critical stenosis of proximal left anterior descending artery (LAD) and stenosis of second marginal branch (Mg). RCA was without significant stenosis after PCI performed 7 years before.
Figure 5
Figure 5
(A) Subtotal LICA stenosis of the same coronary unstable patient (recent amaurosis fugax of the left eye), (B) CAS performed with usage of proximal NPD (flow reversal), (C) final result after stent implantation.
Figure 6
Figure 6
The patient was operated off pump, a total arterial revascularization (TAMR) was performed: LIMA-LAD, Radial Artery (RA): Y-anastomosis.

References

    1. Kablak-Ziembicka A, Tracz W, Przewlocki T, et al. Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart. 2004;90(11):1286–90. - PMC - PubMed
    1. Hertzer NR, Loop FD, Beven EG, et al. Surgical staging for simultaneous coronary and carotid disease: a study including prospective randomization. J Vasc Surg. 1989;9(3):455–63. - PubMed
    1. Schwartz LB, Bridgman AH, Kieffer RW, et al. Asymptomatic carotid artery stenosis and stroke in patients undergoing cardiopulmonary bypass. J Vasc Surg. 1995;21(1):146–53. - PubMed
    1. Kallikazaros I, Tsioufis C, Sideris S, et al. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke. 1999;30:1002–7. - PubMed
    1. Pieniazek P, Musialek P, Kablak-Ziembicka A, et al. Carotid artery stenting with patient- and lesion-tailored selection of the neuroprotection system and stent type: early and 5-year results from a prospective academic registry of 535 consecutive procedures (TARGET-CAS) J Endovasc Ther. 2008;15:249–262. - PubMed